Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Rivaroxaban For Suspension (Xarelto) in shortage?

Rivaroxaban For Suspension is listed by FDA as being discontinued by at least one maker (updated Sep 18, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Xarelto, For Suspension, 155 mg (NDC 50458-575-01)
    Janssen PharmaceuticalsBeing discontinuedUpdated Sep 18, 2026Discontinued Sep 18, 2026

    Business Decision

    Maker contact: 800-526-7736

Rivaroxaban For Suspension shortage questions

Is Rivaroxaban For Suspension (Xarelto) in shortage?

Rivaroxaban For Suspension is listed by FDA as being discontinued by at least one maker (updated Sep 18, 2026).

What should I do if I can’t get Rivaroxaban For Suspension?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.